Antithrombin Supplementation in ECMO

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

July 28, 2017

Primary Completion Date

May 15, 2019

Study Completion Date

May 15, 2019

Conditions
Extracorporeal Membrane Oxygenation
Interventions
DRUG

Antithrombin supplementation

antithrombin concentrate will be supplemented to maintain a functional antithrombin level between 80%-120%

DRUG

No antithrombin supplementation

"supplementation of antithrombin will not be provided unless heparin resistance occurs"

Trial Locations (1)

20122

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan

All Listed Sponsors
collaborator

The Mediterranean Institute for Transplantation and Advanced Specialized Therapies

OTHER

lead

Policlinico Hospital

OTHER

NCT03208270 - Antithrombin Supplementation in ECMO | Biotech Hunter | Biotech Hunter